Ping An Biomedical Co. Cash Flow Statement Analysis

Operating, investing, and financing activities in millions CNY

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Ping An Biomedical Co., Ltd. (PASW) - Annual data in millions CNY
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep 2025Dec 2024Sep 2023Sep 2022Sep 2021Sep 2020
Operating Activities
Net Income-12.83-1.28-0.997.235.211.92
Depreciation & Amortization0.010.010.030.020.390.34
Deferred Income Tax-1.530.01-0.010.05-0.560.00
Change in Working Capital-1.7715.77-5.1413.98-38.66-11.77
Change in Accounts Receivable14.176.539.88-7.79-28.89-14.35
Change in Inventory-0.313.061.4411.39-10.188.50
Change in Accounts Payable-5.645.78-9.8411.345.19-13.75
Change in Other Working Capital-8.060.39-7.260.05-5.6117.48
Other Operating Activities-1.170.130.380.44-0.56-0.79
Net Cash from Operating Activities-6.4314.63-6.0821.09-31.37-7.14
Investing Activities
Capital Expenditures0.000.000.00-0.02-0.03-0.04
Other Investing Activities0.0015.00-3.37-30.230.000.00
Net Cash from Investing Activities0.0015.00-3.37-30.26-0.03-0.04
Financing Activities
Debt Repayment-95.41-29.77-63.77-71.19-22.37-17.38
Common Stock Issued108.190.000.000.010.000.00
Dividends Paid0.00-0.32-9.60-4.830.00-5.40
Other Financing Activities77.130.000.00-11.6525.325.65
Net Cash from Financing Activities43.66-30.098.8710.2431.454.87
Summary
Effect of Forex Changes on Cash-0.670.000.00-0.01-0.100.00
Net Change in Cash36.57-0.46-0.581.07-0.05-2.56
Cash at Beginning of Period0.130.591.170.110.160.00
Cash at End of Period36.700.130.591.170.110.00
Free Cash Flow-6.4314.63-6.0821.06-31.40-7.18
Supplemental Disclosures
Interest Paid0.310.711.951.491.241.20
Income Taxes Paid0.000.222.121.913.412.33